Are we in an AI bubble? And will it be AI or tariffs that determine the trajectory of the market going forward? Read about my ...

Upgraded Relay Therapeutics to a buy after valuation decline. Read more on RLAY's pipeline progress, financial health, and ...

Sixth Street Specialty trades at a 42% NAV premium with strong coverage and stable earnings, but upside is limited at current ...